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The effect of β-alanine on buffering capacity and exercise 
performance during and following high-intensity exercise in 
healthy males. 
Intense exercise induced acidosis occurs from the accumulation of 
hydrogen ions as by-products of anaerobic metabolism. This can have a 
deleterious effect on the skeletal muscles, consequently hindering 
performance at high exercise intensities. Oral ingestion of ß-alanine, a 
limiting precursor of the intracellular physiochemical buffer carnosine 
in skeletal muscle, may counteract any detrimental effect of acidosis 
and benefit performance.  
Five healthy untrained males (age 23.8 ± 2.8 yr) ingested either ß-
alanine (BA) (4.8 g.d-1 for 4wk, followed by 6.4 g.d-1 for 2wk) or placebo 
(PL) (CaCO3). Muscle carnosine was measured using single voxel MRS 
and analysed using jMRUI software to determine concentration relative 
to standard carnosine solutions. 
• 6wk supplementation of ß-alanine enhanced the potential for 
intracellular buffering capacity by increasing muscle carnosine 
concentration by 26% in the gastrocnemius.  
• Greater muscle carnosine concentration enhanced CCT110% TTE by 
~16s (BA, 155.00 ± 19.03s; PL, 134.60 ± 26.16s) (p<0.05), however, it 
did not translate into enhanced performance in the RSA protocol. 
• Significant elevations in plasma lactate following CCT110% supports 
that ß-alanine supplementation may effect anaerobic metabolism 
during single-bout high-intensity exercise. No differences were 
observed following the multiple-bout high-intensity exercise. 
Results: 
Introduction: 
Methods: 
The aim of this study was to investigate the effect of ß-alanine as an 
ergogenic aid during high intensity exercise performance in healthy 
untrained males.  
Aim: 
FIG. 1: Supplementation and Exercise Protocols. MRS; Magnetic Resonance 
Spectroscopy, RSA: Repeated Sprint Ability, CCT; Cycle Capacity Test 
Each exercise trial consisted of two exercise tests performed over 
consecutive days: 
• DAY ONE; Repeated Sprint Ability (RSA) Test - 5 x 6s cycling sprints, 
24s passive recovery. Peak and average power output recorded. 
• DAY TWO; Cycling Capacity Test (CCT) - Cycling at 110% Wmax (from 
VO2 test). Time to exhaustion recorded. 
FIG. 2: Schematic representation of repeated-sprint ability exercise to be conducted 
on day one of each experimental trial. B, baseline; Bl, blood sample; WU, warm-up. 
FIG. 3: Changes in carnosine 
concentration in the 
gastrocnemius prior and post 
6wk chronic supplementation 
of placebo and β-alanine.        
n = 3. Values expressed as 
mean ± SEM. * p<0.05 from PL 
at 6 weeks, # p<0.05 from pre 
supplementation (Week 0).  
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FIG. 5: Participant Time To 
Exhaustion (sec) between 
supplement groups during the 
CCT110%. Values expressed as 
mean ± SEM. * p<0.05 from PL. 
  
 
Conclusions: 
FIG. 4: Participant Peak Power Output (PPO) and Average Power Output 
(APO) (W) between groups for each of the five sprints of the 5 x 6s RSA 
test. Values expressed as mean ± SEM.  
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